Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: EUR
Unlock Free Earnings Estimates
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 14, 2024 16:59 ET
Nov 14, 2024 16:23 ET
Sep 23, 2024 16:04 ET
Sep 3, 2024 17:16 ET
Read more